Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 862 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04932928Recruiting
Using a glucose sensor to improve type 2 diabetes
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
SeoulAges 19–80 - NCT05887635Recruiting
RF treatment of the duodenum for type 2 diabetes control
This trial tests whether a procedure that uses heat energy (radiofrequency vapor ablation) applied in the first part of the small intestine (duodenum) can improve blood sugar control in adults with type 2 diabetes. It may help lower blood sugar when standard oral medicines are not keeping it in range.
SantiagoAges 18–65 - NCT06471634Recruiting
Improving sleep and reducing sitting time in type 2 diabetes
This study tests whether a program to improve sleep and reduce sitting time can help people with type 2 diabetes. It combines cognitive behavioral therapy for insomnia with tips to move more during the day.
Leicester, LeicestershireAges 18–75 - NCT07184775Recruiting
CGM vs finger-stick for type 2 diabetes in pregnancy
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Sewell, New JerseyAges 18 years+ - NCT06924697Enrolling by invitation
Testing a diabetes drug to help men quit smoking
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05307731RecruitingPhase 4
Fingolimod for adults with type 2 diabetes
This trial studies whether fingolimod can improve diabetes in adults with type 2 diabetes who are not yet on many medications. It will mainly check whether the drug is safe and whether it can help control blood sugar over time.
ShenyangAges 18–70 - NCT07423637Recruiting
Early automated insulin delivery for new type 1 diabetes
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
EspooAges 7–16 - NCT07176793Recruiting
Breastfeeding support after gestational diabetes
This study tests a breastfeeding support program for people who had gestational diabetes during pregnancy. The goal is to see if this support helps them breastfeed longer and stay healthy.
Sacramento, CaliforniaAges 18 years+ - NCT05268250Recruiting
Program to help school families cope with type 1 diabetes stress
This trial tests a structured program and screening approach to help school-age children and their families who are feeling significant stress about diabetes. It may help by identifying distress early and offering targeted support alongside an intensive diabetes care plan.
Jacksonville, FloridaAges 8–65 - NCT06532461Recruiting
Comparing 3 vs 7 day insulin pump wear in teens with type 1 diabetes
This study tests if wearing an insulin pump set for 7 days is as safe and effective as changing it every 3 days. It is for children and teens with type 1 diabetes who already use the Medtronic 780G system.
Herlev, CapitalAges 7–18 - NCT07341373RecruitingPhase 1
Testing a new insulin delivery method for type 1 diabetes
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
Chula Vista, CaliforniaAges 18–60 - NCT06496412Recruiting
Fecal transplant for brain health in type 1 diabetes
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
Changsha, HunanAges 18–60 - NCT07807280Recruiting
Learning carb counting with a continuous glucose monitor
This study tests a new way to learn carb counting using a continuous glucose monitor (CGM). It may help you improve your blood sugar control without needing more injections.
Los Angeles, CaliforniaAges 18 years+ - NCT07666789Recruiting
Second Islet Transplant for type 1 diabetes
This study looks at how well a second islet transplant works in people with type 1 diabetes whose first transplant stopped producing insulin or caused dangerous low blood sugar. It aims to see if getting another transplant can help control blood sugar again.
MontpellierAges 18 years+ - NCT06708780RecruitingPhase 1
Treg cell therapy for type 1 diabetes
This trial tests whether giving your own regulatory T cells (a type of immune cell) back to you can help slow or stop the immune attack on your pancreas in type 1 diabetes. It is for people aged 8 to 65 who still make some insulin.
Nanjing, JiangsuAges 8–65 - NCT05767450Recruiting
Test for early type 1 diabetes in children
This study looks at children who have just started insulin for new-onset type 1 diabetes. It aims to test an intervention early in the course of the disease, which may help change how the immune system and diabetes progress.
Milan, MilanAges 7–17 - NCT07592000RecruitingPhase 1/Phase 2
New Treatment for Type 1 Diabetes With Kidney Disease
This study tests a new experimental medication for people with type 1 diabetes who experience dangerous low blood sugar episodes and have early-stage kidney disease. The trial aims to help improve blood sugar control and reduce these risky episodes.
Miami, FloridaAges 18–70 - NCT06575790Recruiting
Comparing simplified meal boluses to carb counting for teens with automated insulin pumps
This study tests if a simpler way of calculating meal insulin works as well as counting carbohydrates for teens using hybrid closed loop (automated insulin) systems. If you're a teen with type 1 diabetes and use an automated pump, this trial could help find an easier mealtime routine.
Aurora, ColoradoAges 14–26 - NCT06239636RecruitingEarly Phase 1
Islet transplant study for adults with type 1 diabetes
This early study tests a new kind of donor islet transplant (UP421) designed to avoid rejection. It's for adults with long-standing type 1 diabetes who have trouble controlling blood sugar despite intensive insulin therapy.
UppsalaAges 30–45 - NCT03710928Recruiting
Very low carbohydrate diet versus standard diet for type 1 diabetes
This study compares a very low carbohydrate diet to a regular diet to see how well blood sugar control works for adults with type 1 diabetes. It may help you understand which eating pattern is easier and safer for managing daily glucose with modern diabetes technology.
Boston, MassachusettsAges 18–40 - NCT07522866Recruiting
Sleep and Type 1 Diabetes Wellness Study
This study explores how sleep quality affects people with type 1 diabetes. Researchers will work with you to understand your sleep patterns and see if improving sleep helps with diabetes management.
Atlanta, GeorgiaAges 31–75 - NCT07507708Recruiting
Smart insulin system with behavior support for type 1 diabetes
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Charlottesville, VirginiaAges 18 years+ - NCT06770621Recruiting
Glucagon response study in new type 1 diabetes
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Brussels, Woluwe-saint-lambertAges 2–30 - NCT07470593Recruiting
Monitoring glucose to detect early pancreatic islet graft loss
This study uses a continuous glucose monitor (CGM) to watch for early signs that a transplanted pancreatic islet graft may be losing function. The goal is to catch problems sooner and help keep the transplant working well.
StrasbourgAges 18 years+
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 862 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.